Marie Kerbie Plaisy, Albert K Minga, Gilles Wandeler, Gad Murenzi, Niharika Samala, Jeremy Ross, Alvaro Lopez, Ephrem Mensah, Renée de Waal, Mark H Kuniholm, Lameck Diero, Sonali Salvi, Rodrigo Moreira, Alain Attia, Ardele Mandiriri, Fabienne Shumbusho, Suzanne Goodrich, Dhanushi Rupasinghe, Paola Alarcon, Fernanda Maruri, Hugo Perrazo, Antoine Jaquet
INTRODUCTION: Liver disease is a leading cause of morbidity and mortality among persons living with HIV (PLHIV). While chronic viral hepatitis has been extensively studied in low- and middle-income countries (LMICs), there is limited information about the burden of metabolic disorders on liver disease in PLHIV. METHODS: We conducted a cross-sectional analysis of baseline data collected between October 2020 and July 2022 from the IeDEA-Sentinel Research Network, a prospective cohort enrolling PLHIV ≥40 years on antiretroviral treatment (ART) for ≥6 months from eight clinics in Asia, Americas, and central, East, southern and West Africa...
April 2024: Journal of the International AIDS Society